These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11763600)

  • 1. [Clinical pharmacology of the new antiarrhythmia agents].
    Tamargo J; Delpón E
    Rev Port Cardiol; 2001 Sep; 20(9):887-98. PubMed ID: 11763600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future of antiarrhythmic drugs.
    Darbar D; Roden DM
    Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in arrhythmia therapy.
    Rodman J; Benditt D
    Clin Pharm; 1983; 2(4):307-11. PubMed ID: 6883960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current and new drugs for the treatment of arrhythmias.
    Auer J; Berent R; Weber T; Lassnig E; Eber B
    Curr Opin Investig Drugs; 2002 Jul; 3(7):1029-36. PubMed ID: 12186263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New anti-arrhythmics--hope or disappointment?].
    Touboul P
    Arch Mal Coeur Vaiss; 2004 Nov; 97(11):1048-53. PubMed ID: 15609905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacology of antiarrhythmia agents: the new aspects].
    Kaverina NV; Chichkanov GG
    Eksp Klin Farmakol; 2003; 66(2):46-52. PubMed ID: 12962048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beat-to-beat variability of repolarization: a new parameter to determine arrhythmic risk of an individual or identify proarrhythmic drugs.
    Oosterhoff P; Oros A; Vos MA
    Anadolu Kardiyol Derg; 2007 Jul; 7 Suppl 1():73-8. PubMed ID: 17584687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy.
    Billman GE
    Pharmacol Ther; 2008 Oct; 120(1):54-70. PubMed ID: 18708091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New fields of research in pharmacological antiarrhythmic therapy].
    Hatem S
    Arch Mal Coeur Vaiss; 2004 Nov; 97(11):1054-7. PubMed ID: 15609906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A; Starmer CF; Bezerianos A
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New use of antiarrhythmia drugs in Saskatchewan.
    Rawson NS; Cox JL; Stang M; Rawson MJ
    Can J Cardiol; 2002 Jan; 18(1):43-50. PubMed ID: 11826328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New pharmacodynamic effects of gidazepam and befol in patients with cardiac arrhythmias].
    Skibitskiĭ VV; Kanorskiĭ SG
    Eksp Klin Farmakol; 1993; 56(5):23-7. PubMed ID: 7906171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance and risks of drugs in the treatment of arrhythmias due to infarction].
    Fourrié JL; Libersa CC
    Soins Cardiol; 1984 Feb; (12):26-33. PubMed ID: 6562734
    [No Abstract]   [Full Text] [Related]  

  • 15. [Arrhythmia risk stratification in patients with heart failure: prognostic evaluation of arrhythmia risk].
    Lombardi F
    Ital Heart J Suppl; 2001 Dec; 2(12):1284-90. PubMed ID: 11838349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification and pharmacology of antiarrhythmic drugs.
    Kowey PR; Marinchak RA; Rials SJ; Bharucha DB
    Am Heart J; 2000 Jul; 140(1):12-20. PubMed ID: 10874257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on new antiarrhythmic drugs.
    Morton PG
    Crit Care Nurs Clin North Am; 1994 Mar; 6(1):69-83. PubMed ID: 8192885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dispersion of ventricular recovery time as a new marker of arrhythmogenic risk].
    Ducceschi V; Sarubbi B; Esposito R; Manzo G; Mayer MS; Santangelo L; Iacono A
    Cardiologia; 1995 May; 40(5):355-60. PubMed ID: 8529247
    [No Abstract]   [Full Text] [Related]  

  • 19. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):442-7. PubMed ID: 14558294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Initial experience with modification of dosage of anti-arrhythmic agents using telephone transmission of the electrocardiogram].
    Bartůnĕk E; Zapletalová J; Kotrlíková E; Gorican K; Chochola M
    Cas Lek Cesk; 1989 Jan; 128(4):114-6. PubMed ID: 2720743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.